Data explainer · July 2026

Semaglutide price trends & cost trajectories

Sticker prices don't predict spend — pricing models do. This page turns our July 2026 dataset into trajectory math: what each structure costs across a treatment year, and how the dose ladder changes your bill.

Key facts. June → July 2026: no headline changes among tracked providers. The market has consolidated into flat-rate (~$145/mo, stable) and membership-plus-medication (~$178–$300+ all-in). Over 12 months the gap between structures is roughly $400–$1,900.
How we rank. SemaglutideGLPOne is affiliate-supported and may have a business or referral relationship with providers it reviews. Rankings are editorial; providers cannot pay for placement. Compounded semaglutide is not FDA-approved. Details checked July 2026 — verify with each provider. Not medical advice.

Cumulative spend across a treatment year

Dose ladder: what each step costs

Semaglutide titrates 0.25 → 2.4 mg over ~16 weeks. Under flat-rate the price is stable; under dose-tiered models it can climb.

Weekly doseFlat-rate (NexLife)Dose-tiered (illustrative)Gap/mo
0.25 mg (start)$145~$165~$20
0.5 mg$145~$189~$44
1.0 mg$145~$219~$74
1.7 mg$145~$259~$114
2.4 mg (maintenance)$145~$289~$144

Frequently asked questions

Are compounded semaglutide prices going up or down in 2026?

Among providers we track, advertised headline pricing was broadly stable from June to July 2026. The structural trend since the FDA resolved the brand shortage has been consolidation into flat-rate and membership models.

What will 12 months of semaglutide actually cost me?

It depends on the pricing model, not the starting sticker: roughly $1,740 on a $145/mo flat plan, ~$2,100–$3,600 on membership-plus-medication, and ~$15,600–$16,800 at brand retail without insurance.

Why does my semaglutide price rise even though I signed up low?

Most likely you're on a membership or dose-tiered plan: the advertised price didn't include the recurring fee, or it applied to the starting dose. Flat-rate plans avoid both by holding one price across the eligible dose range.